UK markets closed

Minerva Surgical, Inc. (UTRS)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00100.0000 (0.00%)
As of 01:18PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 8.88k
Enterprise value 32.43M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.00
Price/book (mrq)0.00
Enterprise value/revenue 0.63
Enterprise value/EBITDA -1.60

Trading information

Stock price history

Beta (5Y monthly) 0.68
52-week change 3-99.98%
S&P500 52-week change 322.38%
52-week high 314.0000
52-week low 30.0010
50-day moving average 30.5150
200-day moving average 32.1904

Share statistics

Avg vol (3-month) 32.65k
Avg vol (10-day) 33.49k
Shares outstanding 58.88M
Implied shares outstanding 68.88M
Float 82.65M
% held by insiders 10.43%
% held by institutions 170.08%
Shares short (15 Dec 2023) 437.42k
Short ratio (15 Dec 2023) 40.51
Short % of float (15 Dec 2023) 43.70%
Short % of shares outstanding (15 Dec 2023) 40.42%
Shares short (prior month 15 Nov 2023) 42.06k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:20
Last split date 302 Oct 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin -64.71%
Operating margin (ttm)-50.95%

Management effectiveness

Return on assets (ttm)-27.34%
Return on equity (ttm)-160.07%

Income statement

Revenue (ttm)51.69M
Revenue per share (ttm)8.31
Quarterly revenue growth (yoy)-4.90%
Gross profit (ttm)N/A
EBITDA -25.56M
Net income avi to common (ttm)-33.45M
Diluted EPS (ttm)-7.6100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)11.12M
Total cash per share (mrq)1.25
Total debt (mrq)43.55M
Total debt/equity (mrq)215.01%
Current ratio (mrq)1.88
Book value per share (mrq)2.28

Cash flow statement

Operating cash flow (ttm)-38.73M
Levered free cash flow (ttm)-18.49M